Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · Real-Time Price · USD
5.45
-0.28 (-4.89%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Cryo-Cell International Market Cap
Cryo-Cell International has a market cap or net worth of $45.42 million as of April 25, 2025. Its market cap has decreased by -26.50% in one year.
Market Cap
45.42M
Enterprise Value
55.80M
1-Year Change
-26.50%
Ranking
Category
Stock Price
$5.45
Market Cap Chart
Since December 1, 1998, Cryo-Cell International's market cap has increased from $21.70M to $45.42M, an increase of 109.32%. That is a compound annual growth rate of 2.84%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 25, 2025 | 45.40M | -23.95% |
Dec 31, 2024 | 59.70M | 25.42% |
Dec 29, 2023 | 47.60M | 32.22% |
Dec 30, 2022 | 36.00M | -63.60% |
Dec 31, 2021 | 98.90M | 70.22% |
Dec 31, 2020 | 58.10M | 4.50% |
Dec 31, 2019 | 55.60M | -4.96% |
Dec 31, 2018 | 58.50M | -14.85% |
Dec 29, 2017 | 68.70M | 121.61% |
Dec 30, 2016 | 31.00M | 6.90% |
Dec 31, 2015 | 29.00M | 21.34% |
Dec 31, 2014 | 23.90M | 20.10% |
Dec 31, 2013 | 19.90M | -14.96% |
Dec 31, 2012 | 23.40M | -0.43% |
Dec 30, 2011 | 23.50M | -16.67% |
Dec 31, 2010 | 28.20M | 34.93% |
Dec 31, 2009 | 20.90M | 326.53% |
Dec 31, 2008 | 4.90M | -46.74% |
Dec 31, 2007 | 9.20M | -65.28% |
Dec 29, 2006 | 26.50M | -32.91% |
Dec 30, 2005 | 39.50M | -19.22% |
Dec 31, 2004 | 48.90M | 431.52% |
Dec 31, 2003 | 9.20M | -50.27% |
Dec 31, 2002 | 18.50M | -65.80% |
Dec 31, 2001 | 54.10M | 132.19% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 794.31B |
UnitedHealth Group | 381.06B |
Johnson & Johnson | 371.93B |
AbbVie | 329.14B |
Novo Nordisk | 272.76B |
Abbott Laboratories | 223.47B |
AstraZeneca | 214.65B |
Novartis AG | 211.71B |